ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity

被引:63
作者
Savasan, S
Lee, SK
Ginsburg, D
Tsai, HM
机构
[1] Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Wayne State Univ, Childrens Hosp Michigan, Div Hematol Oncol, Detroit, MI USA
[4] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA
[7] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
D O I
10.1182/blood-2002-12-3796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deficiency of von Willebrand factor (VWF) cleaving protease ADAMTS13 is associated with the development of thrombotic thrombocytopenic purpura (TTP). A case of congenital TTP that was previously reported to have normal ADAMTS13 activity was analyzed at the molecular level. Reanalysis of plasma VWF cleaving protease activity using a different assay revealed that the patient had less than 0.1 U/L ADAMTS13 protease activity, while the parents were both partially deficient. Sequence analysis of DNA amplified by polymerase chain reaction showed that the patient was homozygous for a novel TT deletion in exon 15 of the ADAMTS13 gene resulting in a frameshift, while both parents were heterozygous for the same mutation. Taken together with other recent reports, all the cases of hereditary TTP studied by DNA sequence analysis to date appear to be due to mutations within the ADAMTS13 gene. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:4449 / 4451
页数:3
相关论文
共 19 条
[1]  
ASADA Y, 1985, THROMB RES, V38, P467
[2]   Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura [J].
Bianchi, V ;
Robles, R ;
Alberio, L ;
Furlan, M ;
Lämmle, B .
BLOOD, 2002, 100 (02) :710-713
[3]  
Chow TW, 1998, AM J HEMATOL, V57, P293, DOI 10.1002/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO
[4]  
2-P
[5]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[6]   Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma [J].
Kentouche, K ;
Budde, U ;
Furlan, M ;
Scharfe, V ;
Schneppenheim, R ;
Zintl, F .
ACTA PAEDIATRICA, 2002, 91 (10) :1056-1059
[7]   Mutations and common polymorphisms in ADAMTS13 gene responsiblefor von Willebrand factor-cleaving protease activity [J].
Kokame, K ;
Matsumoto, M ;
Soejima, K ;
Yagi, H ;
Ishizashi, H ;
Funato, M ;
Tamai, H ;
Konno, M ;
Kamide, K ;
Kawano, Y ;
Miyata, T ;
Fujimura, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11902-11907
[8]   Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura [J].
Levy, GG ;
Nichols, WC ;
Lian, EC ;
Foroud, T ;
McClintick, JN ;
McGee, BM ;
Yang, AY ;
Siemieniak, DR ;
Stark, KR ;
Gruppo, R ;
Sarode, R ;
Shurin, SB ;
Chandrasekaran, V ;
Stabler, SP ;
Sabio, H ;
Bouhassira, EE ;
Upshaw, JD ;
Ginsburg, D ;
Tsai, HM .
NATURE, 2001, 413 (6855) :488-494
[9]   Changes in health and disease of the metalloprotease that cleaves von Willebrand factor [J].
Mannucci, PM ;
Canciani, MT ;
Forza, I ;
Lussana, F ;
Lattuada, A ;
Rossi, E .
BLOOD, 2001, 98 (09) :2730-2735
[10]   Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders [J].
Moore, JC ;
Hayward, CPM ;
Warkentin, TE ;
Kelton, JG .
BLOOD, 2001, 98 (06) :1842-1846